Merck & Co. Inc. (NYSE:MRK) forty third Annual J.P. Morgan Healthcare Convention January 13, 2025 7:30 PM ET
Firm Individuals
Robert Davis – Chairman and CEO
Dean Li – Govt VP & President of Merck Analysis Laboratories
Convention Name Individuals
Chris Schott – JPMorgan
Chris Schott
Good afternoon, all people. I am Chris Schott from JPMorgan, and it is my pleasure to be introducing Merck at this time. From the corporate, now we have Rob Davis, Chairman and CEO; in addition to Dean Li, who’s the President of Merck Analysis Labs. So Rob and Dean, Completely happy New 12 months. Thanks for becoming a member of us. We look ahead to our presentation from Rob and Dean, after which we will soar into some Q&A from there. So with that…
Robert Davis
Thanks. Nice. Good afternoon, all people. Earlier than we get began, I’ll level out that I shall be making forward-looking statements. So if you need to see our data on this, please see our web site and you may get — be taught extra about what we do and we take into consideration making ahead statements, and clearly, they carry with them their very own dangers and uncertainties.
As you mirror on the place Merck is and the place we have been, hopefully, you see what we see. And I can let you know, I really feel superb about the place the workforce is in executing on our strategic priorities. And if I take into consideration that, most significantly, it is the progress we’re making, advancing the pipeline and augmenting the pipeline. And importantly, we proceed to give attention to scientific innovation with the affected person actually on the heart because the core of what we see as a driver of long-term sustainable worth, each for our shareholders and for all of our stakeholders.
We’re now at a bit of over 3.5 years since I took over the function of CEO and
